METHODS OF USING MYT1 INHIBITORS
Disclosed are methods of using inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1), e.g., in the treatment of subjects in need thereof. L'invention concerne des procédés d'utilisation d'inhibiteurs de la kinase inhibitrice de cdc2 spécifique de la tyrosine et d...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
07.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are methods of using inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1), e.g., in the treatment of subjects in need thereof.
L'invention concerne des procédés d'utilisation d'inhibiteurs de la kinase inhibitrice de cdc2 spécifique de la tyrosine et de la thréonine (Myt1), par exemple, dans le traitement de sujets en ayant besoin. |
---|---|
Bibliography: | Application Number: CA20213173955 |